Studies showed that Cyclooxygenase-2 (COX-2)-selective NSAIDs were associated with less symptomatic and endoscopically detected ulcers as opposed to non-selective NSAIDs like naproxen, ibuprofen etc. The symptoms were not predictive of the presence of mucosal injury. This evidence concerns the gene PTGS2 and ulcer disease.